Literature DB >> 28153352

The impact of age on serum allergen-specific IgE to inhaled molecular components.

M A Tosca1, M Silvestri1, R Olcese1, A Pistorio2, G A Rossi1, G Ciprandi3.   

Abstract

BACKGROUND: Respiratory allergy is characterised by an IgE-mediated reaction. The immune system functions, including IgE production, progressively decline over time, such as growing up and ageing. Molecular-based allergy diagnostic defines sensitisation profile. This study aimed to evaluate the impact of age on serum allergen-specific IgE to molecular component levels in a large sample of subjects.
METHODS: Serum IgE to: Phl p1, Bet v1, Ole e1, Cup a1, Par j2, Can f1, Der p2, and Fel d1 were assessed by ISAC method. Sera from 2788 patients, 1230 males (44.1%) and 1558 females (55.9%), median age 23 years (1st and 3rd quartiles: 9.7-49.7 years; age range: 1 month-103 years) were analysed.
RESULTS: The number of positive tests (i.e. sensitisation) tended to increase between birth and school-age till young adulthood and then decreased (p<0.0001) with the exception of Fel d 1 (p=0.14). A similar age-dependent trend was observed considering the levels of each allergen components: the levels of each allergen component, with the exception of Fel d 1, tended to increase till early adulthood and then to decrease reaching the lowest levels in the elderly.
CONCLUSIONS: Allergen-specific IgE production to inhaled molecular components trend to reduce with ageing, but with differences between allergens. This phenomenon should be adequately evaluated managing allergic patients.
Copyright © 2016 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Age; Allergen-specific IgE; ISAC; Inhaled allergen; Molecular component; Serum

Mesh:

Substances:

Year:  2017        PMID: 28153352     DOI: 10.1016/j.aller.2016.10.004

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  2 in total

1.  Allergy diagnosis from symptoms to molecules, or from molecules to symptoms: a comparative clinical study.

Authors:  N Mothes-Luksch; G Jordakieva; L Hinterhölzl; A N Jensen; P K Hallmann; M Kundi; E Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2018-09-11       Impact factor: 4.084

2.  Pru p 3 sensitization in children with allergy to Parietaria pollens.

Authors:  Giorgio Ciprandi; Paolo Del Barba; Michela Silvestri; Salvatore Barberi; Maria Angela Tosca
Journal:  Acta Biomed       Date:  2019-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.